| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Tumor Suppression & Functional Genomics Project, National Cancer Center Research Institute, Tokyo 104-0045 [M. Y., M. K., M. M., T. F., H. F., T. M., Y. M.], and Department of Genetics, Institute of Medical Science, University of Tokyo, Tokyo 108-0071 [M. Y., M. S.], Japan
The tumor suppressor gene TSLC1, which we recently identified in human non-small cell lung cancer, encodes a membrane glycoprotein of the immunoglobulin superfamily. Here, we report that TSLC1 directly associates with DAL-1, a gene product of another lung tumor suppressor belonging to the protein 4.1 family. TSLC1 additionally interacts with the actin filament through DAL-1 at the cell-cell attached site where the complex formation of TSLC1 and DAL-1 is dependent on the integrity of actin cytoskeleton. Redistribution of both TSLC1 and DAL-1 to the newly generated membrane ruffling areas suggests that these proteins are also involved in cell motility accompanying the actin rearrangement. Furthermore, restoration of TSLC1 expression strongly suppressed the metastasis of a human non-small cell lung cancer cell line, A549, from the spleen to the liver in nude mice. These findings, together with frequent loss of their expression in lung cancers, suggest that TSLC1 and DAL-1 play a critical role in the same pathway involved in the suppression of lung tumor formation and metastasis.
This article has been cited by other articles:
![]() |
S. J. Hasstedt, I. D. Bezemer, P. W. Callas, C. Y. Vossen, W. Trotman, R. P. Hebbel, C. Demers, F. R. Rosendaal, and E. G. Bovill Cell adhesion molecule 1: a novel risk factor for venous thrombosis Blood, October 1, 2009; 114(14): 3084 - 3091. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Dickinson, E. I. Surace, M. Cambell, R. J. Higgins, C. M. Leutenegger, A. W. Bollen, R. A. LeCouteur, and D. H. Gutmann Expression of the Tumor Suppressor Genes NF2, 4.1B, and TSLC1 in Canine Meningiomas Vet. Pathol., September 1, 2009; 46(5): 884 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kawano, W. Ikeda, M. Kishimoto, H. Ogita, and Y. Takai Silencing of ErbB3/ErbB2 Signaling by Immunoglobulin-like Necl-2 J. Biol. Chem., August 28, 2009; 284(35): 23793 - 23805. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Reamon-Buettner and J. Borlak Epigenetic Silencing of Cell Adhesion Molecule 1 in Different Cancer Progenitor Cells of Transgenic c-Myc and c-Raf Mouse Lung Tumors Cancer Res., September 15, 2008; 68(18): 7587 - 7596. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Maurel, S. Einheber, J. Galinska, P. Thaker, I. Lam, M. B. Rubin, S. S. Scherer, Y. Murakami, D. H. Gutmann, and J. L. Salzer Nectin-like proteins mediate axon Schwann cell interactions along the internode and are essential for myelination J. Cell Biol., August 27, 2007; 178(5): 861 - 874. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wakayama, Y. Sai, A. Ito, Y. Kato, M. Kurobo, Y. Murakami, E. Nakashima, A. Tsuji, Y. Kitamura, and S. Iseki Heterophilic Binding of the Adhesion Molecules Poliovirus Receptor and Immunoglobulin Superfamily 4A in the Interaction Between Mouse Spermatogenic and Sertoli Cells Biol Reprod, June 1, 2007; 76(6): 1081 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. Surace, A. Strickland, R. A. Hess, D. H. Gutmann, and C. K. Naughton Tslc1 (Nectin-Like Molecule-2) Is Essential for Spermatozoa Motility and Male Fertility J Androl, November 1, 2006; 27(6): 816 - 825. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. van der Weyden, M. J. Arends, O. E. Chausiaux, P. J. Ellis, U. C. Lange, M. A. Surani, N. Affara, Y. Murakami, D. J. Adams, and A. Bradley Loss of TSLC1 Causes Male Infertility Due to a Defect at the Spermatid Stage of Spermatogenesis. Mol. Cell. Biol., May 1, 2006; 26(9): 3595 - 3609. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Dong, F. Xu, Y. Gong, J. Gao, P. Lin, T. Chen, Y. Peng, B. Qiang, J. Yuan, X. Peng, et al. Crystal Structure of the V Domain of Human Nectin-like Molecule-1/Syncam3/Tsll1/Igsf4b, a Neural Tissue-specific Immunoglobulin-like Cell-Cell Adhesion Molecule J. Biol. Chem., April 14, 2006; 281(15): 10610 - 10617. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Masuda, S. Kikuchi, T. Maruyama, M. Sakurai-Yageta, Y. N. Williams, H. P. Ghosh, and Y. Murakami Tumor Suppressor in Lung Cancer (TSLC)1 Suppresses Epithelial Cell Scattering and Tubulogenesis J. Biol. Chem., December 23, 2005; 280(51): 42164 - 42171. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Arase, A. Takeuchi, M. Unno, S. Hirano, T. Yokosuka, H. Arase, and T. Saito Heterotypic interaction of CRTAM with Necl2 induces cell adhesion on activated NK cells and CD8+ T cells Int. Immunol., September 1, 2005; 17(9): 1227 - 1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Boles, W. Barchet, T. Diacovo, M. Cella, and M. Colonna The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM Blood, August 1, 2005; 106(3): 779 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kikuchi, D. Yamada, T. Fukami, M. Masuda, M. Sakurai-Yageta, Y. N. Williams, T. Maruyama, H. Asamura, Y. Matsuno, M. Onizuka, et al. Promoter Methylation of DAL-1/4.1B Predicts Poor Prognosis in Non-Small Cell Lung Cancer Clin. Cancer Res., April 15, 2005; 11(8): 2954 - 2961. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kakunaga, W. Ikeda, S. Itoh, M. Deguchi-Tawarada, T. Ohtsuka, A. Mizoguchi, and Y. Takai Nectin-like molecule-1/TSLL1/SynCAM3: a neural tissue-specific immunoglobulin-like cell-cell adhesion molecule localizing at non-junctional contact sites of presynaptic nerve terminals, axons and glia cell processes J. Cell Sci., March 15, 2005; 118(6): 1267 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sasaki, I. Nishikata, T. Shiraga, E. Akamatsu, T. Fukami, T. Hidaka, Y. Kubuki, A. Okayama, K. Hamada, H. Okabe, et al. Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia Blood, February 1, 2005; 105(3): 1204 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Mao, E. Seidlitz, K. Ghosh, Y. Murakami, and H. P. Ghosh The Cytoplasmic Domain Is Critical to the Tumor Suppressor Activity of TSLC1 in Non-Small Cell Lung Cancer Cancer Res., November 15, 2003; 63(22): 7979 - 7985. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ito, Y. Shimada, Y. Hashimoto, J. Kaganoi, T. Kan, G. Watanabe, Y. Murakami, and M. Imamura Involvement of TSLC1 in Progression of Esophageal Squamous Cell Carcinoma Cancer Res., October 1, 2003; 63(19): 6320 - 6326. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shingai, W. Ikeda, S. Kakunaga, K. Morimoto, K. Takekuni, S. Itoh, K. Satoh, M. Takeuchi, T. Imai, M. Monden, et al. Implications of Nectin-like Molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in Cell-Cell Adhesion and Transmembrane Protein Localization in Epithelial Cells J. Biol. Chem., September 12, 2003; 278(37): 35421 - 35427. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |